Skip to main content
Support Quality Journalism.
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just
$1.99
per week
for first 24 weeks
Enjoy unlimited digital access
START TODAY
Get full access to globeandmail.com
Just $1.99 per week
for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //
The Globe and Mail
Member Benefits
Subscribe
Subscribe
Register
Log in
My account
Following
Bookmarks
Reading history
Newsletters
Subscriptions
Settings
Help
My account
Following
Bookmarks
Reading history
Newsletters
Subscriptions
Settings
Help
AdChoices
Canada
World
Business
Investing
Opinion
Politics
Sports
Life
Arts
Drive
Real Estate
Watchlist
Search
Search
Quick links
Horoscopes
Puzzles
Member Benefits
Newsletters
Globe Shop
Investigations
Death Notices (Legacy.com)
Reader services
Subscribe
Following
Subscriptions
Settings
Customer Help
Contact us
Log in
Log out
Medication
Follow
Latest
report on business
B.C. startup Eupraxia attempting rare TSX-only biotech IPO, raising hopes for revival of issues on senior Canadian exchange
February 24
Updated
report on business
Bausch Health shareholder pushes for completion of eye-care spinoff by end of 2021
February 12
Updated
u.s. business
Eli Lilly CFO resigns after probe finds ‘inappropriate communication’ with employees
February 9
Updated
u.s. business
Merck CEO Kenneth Frazier stepping down at the end of June
February 4
Updated
european business
GSK forecasts dip in profit but says plan to split business still on track
February 3
Updated
u.s. business
Pfizer forecasts about $15-billion of COVID-19 vaccine sales in 2021
February 2
Updated
More Stories Below Advertisement
european business
Bayer and Rentschler agrees to help CureVac manufacture its COVID-19 vaccine
February 1
Updated
politics
McKinsey is open to settlement regarding opioid work in the U.S. and Canada
January 29
Updated
u.s. business
EU warns pharmaceuticals to honour COVID-19 vaccine delivery commitments
January 26
Updated
u.s. business
Johnson & Johnson expects to share COVID-19 vaccine data next week
January 26
Updated
report on business
Vancouver’s Khosrowshahi family to launch US$400-million pharma IPO, capitalizing on biotech craze
January 25
Updated
report on business
Shares in B.C.’s Aurinia jump more than 25 per cent on FDA approval to sell lupus drug
January 25
Updated
international business
Investors sue Bayer over stock’s slump in wake of Roundup litigation
January 22
Updated
report on business
Investors flock to Canadian device maker Sernova hoping to transform how diabetes is treated
January 21
Updated
report on business
Bausch Health expects 2020 revenue to exceed previous guidance
January 13
Updated
number cruncher
Wide-moat strategy: 10 U.S. stocks with a sustainable competitive advantage
January 4
Updated
More Stories Below Advertisement
opinion
What Canada needs to do to build a world-class biotech sector
Roberto Bellini
December 23
Updated
u.s. business
Merck signs $356-million U.S. supply deal for experimental COVID-19 treatment
December 23
Updated
number cruncher
20 dividend growth stocks that have weathered the storm
December 21
Updated
report on business
Health Canada has final data needed from Moderna to make a decision on vaccine
December 21
Updated
stars and dogs
The Globe’s stars and dogs for the week
December 18
Updated
opinion
Other countries should follow Canada’s lead in fighting COVID globally
Jeremy Farrar
December 18
Updated
european business
Bayer CEO plans to exit corporate life when term expires in 2024
December 17
Updated
politics
Canadian envoy silent on his knowledge of McKinsey role in Purdue opioid sales
December 14
Updated
international business
AstraZeneca shares fall as investors react to $39-billion Alexion acquisition
December 14
Updated
canada
B.C. medical group launches program to prescribe nature as medication
December 6
Updated
u.s. business
Merck sells stake in vaccine developer Moderna
December 2
Updated
european business
Britain presses on with AstraZeneca vaccine amid questions over trial data
November 27
Updated
world
AstraZeneca likely to run new global trial of its COVID-19 vaccine, CEO says
November 26
Updated
opinion
The credibility of pharmaceutical companies is on the line. Will they get it right?
Jillian Kohler
and
Jonathan Cushing
November 24
Updated
u.s. business
AstraZeneca says its COVID-19 ‘vaccine for the world’ can be 90% effective
November 23
Updated
streetwise newsletter
Streetwise newsletter: Best reads of the week
November 20
Updated
u.s. business
Pfizer applies for U.S. emergency use for COVID-19 vaccine
November 20
Updated
world
Pfizer ends COVID-19 trial with 95% efficacy, to seek emergency-use authorization
November 18
Updated
u.s. business
Amazon Pharmacy launches in several U.S. states as online giant takes on established drug retailers
November 17
Updated
report on business
Pharmaceutical industry offers Ottawa $1-billion to scrap pending drug pricing rules, documents show
November 15
Updated
View More Stories
To view this site properly, enable cookies in your browser. Read our
privacy policy
to learn more.
How to enable cookies